Beijing Friendship Hospital: Rectal Neoplasms trials

The registry lists 10 Rectal Neoplasms studies with Beijing Friendship Hospital as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 2 5No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Rectal Cancer Neoadjuvant Therapy-Real World StudyRecruitingNCT07566559
• Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal CancerNot yet recruitingNCT07397442Phase 2
• Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoadjuvant Therapy for Rectal CancerRecruitingNCT07393048
• Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal CancerNot yet recruitingNCT06304987Phase 2
• Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal CancerRecruitingNCT05845268Phase 2
• Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal CancerRecruitingNCT05245474Phase 2
• Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal CancerActive, not recruitingNCT06056804Phase 2
• Chinese TaTME Registry CollaborativeStatus unknownNCT03416699
• Anastomotic Leakage After Anterior Resection of Rectal CancerStatus unknownNCT03281070
• Laparoscopic Assisted Transanal Total Mesorectal Excision for Rectal Cancer in Low SiteStatus unknownNCT03253302